The Klinique Medical Clinic PCL (BKK:KLINIQ)
Thailand
· Delayed Price · Currency is THB 21.30
-0.50 (-2.29%)
At close: Dec 4, 2025
BKK:KLINIQ Ratios and Metrics
Market cap in millions THB. Fiscal year is January - December.
Millions THB. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2016 |
|---|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 3, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 - 2016 |
| Market Capitalization | 4,686 | 7,150 | 9,240 | 8,525 | - | - | Upgrade
|
| Market Cap Growth | -29.59% | -22.62% | 8.39% | - | - | - | Upgrade
|
| Enterprise Value | 4,695 | 7,093 | 8,436 | 8,748 | - | - | Upgrade
|
| Last Close Price | 21.30 | 30.89 | 38.44 | 34.50 | - | - | Upgrade
|
| PE Ratio | 13.33 | 22.19 | 32.02 | 41.49 | - | - | Upgrade
|
| Forward PE | 12.31 | 19.94 | - | - | - | - | Upgrade
|
| PS Ratio | 1.38 | 2.40 | 4.04 | 5.20 | - | - | Upgrade
|
| PB Ratio | 2.80 | 4.16 | 5.43 | 5.18 | - | - | Upgrade
|
| P/TBV Ratio | 2.82 | 4.18 | 5.44 | 5.19 | - | - | Upgrade
|
| P/FCF Ratio | 17.55 | - | 476.45 | 46.80 | - | - | Upgrade
|
| P/OCF Ratio | 8.43 | 12.95 | 23.94 | 20.90 | - | - | Upgrade
|
| EV/Sales Ratio | 1.39 | 2.38 | 3.69 | 5.34 | - | - | Upgrade
|
| EV/EBITDA Ratio | 6.86 | 12.83 | 15.63 | 26.59 | - | - | Upgrade
|
| EV/EBIT Ratio | 10.26 | 17.80 | 24.44 | 34.21 | - | - | Upgrade
|
| EV/FCF Ratio | 17.59 | - | 435.00 | 48.02 | - | - | Upgrade
|
| Debt / Equity Ratio | 0.40 | 0.38 | 0.27 | 0.19 | 1.29 | 1.91 | Upgrade
|
| Debt / EBITDA Ratio | 0.96 | 0.97 | 0.85 | 0.77 | 0.88 | 0.86 | Upgrade
|
| Debt / FCF Ratio | 2.47 | - | 23.80 | 1.68 | 1.25 | 2.13 | Upgrade
|
| Asset Turnover | 1.10 | 1.00 | 0.84 | 0.96 | 1.20 | - | Upgrade
|
| Inventory Turnover | 5.49 | 6.23 | 6.75 | 7.01 | 4.18 | - | Upgrade
|
| Quick Ratio | 0.75 | 0.91 | 1.54 | 2.08 | 0.16 | 0.02 | Upgrade
|
| Current Ratio | 1.24 | 1.32 | 1.93 | 2.38 | 0.41 | 0.39 | Upgrade
|
| Return on Equity (ROE) | 21.40% | 18.84% | 17.24% | 22.75% | 95.13% | - | Upgrade
|
| Return on Assets (ROA) | 9.31% | 8.35% | 7.94% | 9.39% | 12.07% | - | Upgrade
|
| Return on Capital (ROIC) | 12.58% | 10.98% | 10.48% | 13.79% | 27.72% | - | Upgrade
|
| Return on Capital Employed (ROCE) | 20.80% | 17.70% | 16.60% | 13.60% | 48.60% | 60.40% | Upgrade
|
| Earnings Yield | 7.50% | 4.51% | 3.12% | 2.41% | - | - | Upgrade
|
| FCF Yield | 5.70% | -0.27% | 0.21% | 2.14% | - | - | Upgrade
|
| Dividend Yield | 6.57% | 4.53% | 3.38% | 1.45% | - | - | Upgrade
|
| Payout Ratio | 90.74% | 95.60% | 80.04% | 74.55% | 61.89% | 206.78% | Upgrade
|
| Buyback Yield / Dilution | - | - | -29.64% | -6.06% | - | -202.12% | Upgrade
|
| Total Shareholder Return | 6.57% | 4.53% | -26.26% | -4.61% | - | -202.12% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.